Cargando…

The importance of androgen receptors in breast cancer

BACKGROUND AND AIM: Breast cancer (BC) is the most common malignancy among women worldwide, and one of the leading causes of cancer-related deaths in females. For the breast malignant tumors there are numerous targeted therapies, depending on the receptors expressed. Regulating the process of epithe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niţă, Irina, Niţipir, Cornelia, Toma, Ştefania Andreea, Limbău, Alexandra Maria, Pîrvu, Edvina, Bădărău, Ioana Anca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357358/ https://www.ncbi.nlm.nih.gov/pubmed/34430848 http://dx.doi.org/10.15386/mpr-1842

Ejemplares similares

Correlation between Androgen Receptor Expression and Immunohistochemistry Type as Prognostic Factors in a Cohort of Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study
por: Niță, Irina, et al.
Publicado: (2021)

Histological Aspects and Quantitative Assessment of Ki67 as Prognostic Factors in Breast Cancer Patients: Result from a Single-Center, Cross Sectional Study
por: Niță, Irina, et al.
Publicado: (2020)

Level of education, background and clinical stage as prognostic factors according to RMST function in patients with early and locally advanced breast cancer: a single institution experience from Romania
por: Niţă, Irina, et al.
Publicado: (2022)

The impact of RAS mutation on the treatment strategy of colorectal cancer
por: Pirvu, Edvina Elena, et al.
Publicado: (2023)

Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer—A Retrospective Study from a Tertiary-Level Center in Romania
por: Pîrvu, Edvina Elena, et al.
Publicado: (2023)

An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer—A Systematic Review of Randomized Phase II and III Clinical Trials
por: Stanciu, Ioana-Miruna, et al.
Publicado: (2023)

Aspects Regarding the Influence of Obesity on the Molecular Characteristics of Breast Tumors
por: Pantelimon, Iuliana, et al.
Publicado: (2022)

Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2022)

Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers
por: Parosanu, Andreea Ioana, et al.
Publicado: (2023)

Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature
por: Parosanu, Andreea, et al.
Publicado: (2022)

Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
por: Stanciu, Ioana-Miruna, et al.
Publicado: (2023)

Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort study
por: Nitipir, Cornelia, et al.
Publicado: (2022)

Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer
por: Pirlog, Cristina-Florina, et al.
Publicado: (2022)

The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018)

Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2023)

Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review
por: Stanciu, Ioana-Miruna, et al.
Publicado: (2023)

Cutaneous Melanoma and Glioblastoma Multiforme Association—Case Presentation and Literature Review
por: Orzan, Olguța Anca, et al.
Publicado: (2023)

Human Papillomavirus Infection at the Time of Delivery
por: Radu, Mihaela C, et al.
Publicado: (2021)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

Somatic Symptoms and Sleep Disorders: A Literature Review of Their Relationship, Comorbidities and Treatment
por: Ionescu, Claudiu Gabriel, et al.
Publicado: (2021)

Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
por: Scheau, Cristian, et al.
Publicado: (2021)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

Androgen receptor in breast cancer: The “5W” questions
por: Ravaioli, Sara, et al.
Publicado: (2022)

Influence of Androgen Receptor on the Prognosis of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2020)

Revisiting Androgen Receptor Signaling in Breast Cancer
por: Dai, Charles, et al.
Publicado: (2023)

Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Availability, Toxicology and Medical Significance of Antimony
por: Periferakis, Argyrios, et al.
Publicado: (2022)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.
por: Hall, R. E., et al.
Publicado: (1996)

Proceedings: Oestrogen and androgen receptors in human breast cancer.
por: Engelsman, E., et al.
Publicado: (1974)

Androgen Receptor Expression in Thai Breast Cancer Patients
por: Chottanapund, Suthat, et al.
Publicado: (2016)

Androgen Receptor in Breast Cancer: From Bench to Bedside
por: Chen, Mengyao, et al.
Publicado: (2020)

Androgen receptor gene expression in primary breast cancer
por: Vidula, Neelima, et al.
Publicado: (2019)

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
por: You, Chan-Ping, et al.
Publicado: (2022)

Modulating the Activity of Androgen Receptor for Treating Breast Cancer
por: You, Chan-Ping, et al.
Publicado: (2022)

Androgen receptor in breast cancer and its clinical implication
por: Hackbart, Hannah, et al.
Publicado: (2023)

EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASES
por: Fan, Kevin Yijun, et al.
Publicado: (2023)

Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells—identification of a novel androgen response element
por: Lanzino, Marilena, et al.
Publicado: (2010)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_22pc2fq577042sm8j5bbaf5gfa